Instruction for use: Tobitil

Active substance Tenoxicam

ภาี M01AC02Tenoxicam

Pharmacological group

Non-steroidal anti-inflammatory drug [NSAIDs - Oxicams]

Nosological classification (ICD-10)

G54.1 Disorders of lumbosacral plexus

Sciatica, Neurology radicular origin, spine Pathology, Sciatica lumbosacral, radiculoneuritis

M05 Seropositive rheumatoid arthritis

Rheumatoid arthritis seropositive

M10 Gout

Exacerbation of gout, Acute articular attack with gout, Acute gouty attack, Gouty attack, Recurrent gout attacks, Chronic gout

M25.5 Pain in the joint

Arthralgia, Pain syndrome in musculo-articular diseases, Pain syndrome in osteoarthritis, Pain syndrome in osteoarthritis, Pain syndrome in acute inflammatory diseases of the musculoskeletal system, Pain syndrome in chronic inflammatory diseases of the musculoskeletal system, Pain in the joints, Soreness of the joints, Soreness of joints in severe physical exertion, Painful inflammatory joint damage, Painful conditions of the musculoskeletal system, Painful joint conditions, Painful traumatic affection of joints, Pain in the musculoskeletal system, Pain in Shoulder Joints, Pain in the joints, Joint pain, Joint pain with injuries, Musculoskeletal pain, Pain with osteoarthritis, Pain in the pathology of the joints, Pain in rheumatoid arthritis, Pain in chronic degenerative bone diseases, Pain in chronic degenerative joint diseases, Bone-joint pain, Joint pain, Arthritic pain of rheumatic origin, Articular pain syndrome, Joint pain, Rheumatic pain, Rheumatic pains

M45 Ankylosing spondylitis

Ankylosing spondylarthrosis, Marie-Strumpel disease, Ankylosing spondylitis, Pain syndrome in acute inflammatory diseases of the musculoskeletal system, Pain syndrome in chronic inflammatory diseases of the musculoskeletal system, Bechterew's disease, Ankylosing spondylitis, Diseases of the spinal column, Rheumatic spondylitis, Bechterew-Marie-Strumpel disease

M54.3 Sciatica

Ishialgia, Neuralgia of the sciatic nerve, Sciatic neuritis

M71 Other bursopathies

Bursitis, Bursopathy, Diseases of soft tissues, Osteoarthritis in musculo-articular diseases, Inflammatory disease of soft tissues, Subacute bursitis

M77.9 Other unspecified

Capsule, Periarthritis, Tendonitis, Tendopathy, Periarthropathy

M81.9 Other specified osteoporosis

Osteoporosis due to androgen deficiency, Primary osteoporosis, Osteoporosis in men, Parathyroid osteoporosis, Primary osteoporosis, Post-traumatic osteoporosis, Loss of calcium in bones and teeth, Presennial osteoporosis, Systemic osteoporosis

Composition and form of release

1 tablet, coated, contains tenoxicam 20 mg; in the package of 100 pcs.

pharmachologic effect

Pharmacological action - anti-inflammatory, antipyretic, antiaggregational, analgesic.

Inhibits the synthesis of PG (prostaglandins).

Indications

Pain and inflammation in rheumatoid arthritis, osteoporosis, ankylosing spondylitis, gout and non-pediatric rheumatic conditions (tendinitis, bursitis, sciatica, back pain).

Contraindications

Hypersensitivity, peptic ulcers in the phase of exacerbation and in the anamnesis, gastrointestinal bleeding, acute gastritis, pregnancy, lactation.

Side effects

Dyspeptic disorders, the formation of peptic ulcers, gastrointestinal bleeding, interstitial nephritis, glomerulonephritis, papillary necrosis, nephritic syndrome, edema, headaches, dizziness, drowsiness or insomnia, depression, nervousness, liver function abnormalities, increased serum transaminases, impaired vision, hypocoagulation, allergic reactions.

Dosing and Administration

Inside, 1 tab. per day (with water) at the same time. In acute gouty arthritis - 2 tablets once a day for 2 days, then 1 table. a day for another 5 days.

storage Conditions

In a dry, cool place.

Keep out of the reach of children.

Shelf life

2.5 years.

Do not use after the expiry date printed on the package.